Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). India Glycols's share price for the quarter that ended in Jun. 2026 was ₹986.35. India Glycols's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 67 Mil. Therefore, India Glycols's market cap for the quarter that ended in Jun. 2026 was ₹66,112 Mil.
India Glycols's quarterly market cap
declined
from Dec. 2025 (₹68,113 Mil) to Mar. 2026 (₹56,903 Mil) but then
increased
from Mar. 2026 (₹56,903 Mil) to Jun. 2026 (₹66,112 Mil).
India Glycols's annual market cap
increased
from Mar. 2024 (₹23,439 Mil) to Mar. 2025 (₹34,361 Mil) and
increased
from Mar. 2025 (₹34,361 Mil) to Mar. 2026 (₹56,903 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. India Glycols's Enterprise Value for Today is ₹92,736 Mil.
India Glycols (NSE:INDIAGLYCO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
India Glycols Market Cap Related Terms
India Glycols Market Cap Historical Data
* Premium members only.
The historical data trend for India Glycols's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, India Glycols's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols Market Cap vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's Market Cap distribution charts can be found below:
* The bar in red indicates where India Glycols's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
India Glycols's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
India Glycols (NSE:INDIAGLYCO) has a Market Cap of ₹76,719 Mil as of Aug. 22, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on India Glycols and its competitors. According to the industry distribution chart, India Glycols ranks #500 out of 1634 companies in the Chemicals industry, placing it in the top 30.6%.
Is India Glycols' Market Cap too high?
India Glycols' current Market Cap is ₹76,719 Mil. Based on the distribution chart, India Glycols ranks #500 out of 1634 companies in the Chemicals industry, which is above the industry midpoint. Overall, India Glycols has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Market Cap compare to DOW?
According to the Chemicals industry distribution chart, India Glycols ranks #500 out of 1634 companies for Market Cap. This puts India Glycols in the upper half of its industry. The industry median Market Cap is 311.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Chemicals company?
The median Market Cap among Chemicals companies is 311.65, based on 1,634 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on India Glycols and its competitors. For the Chemicals industry, the median Market Cap is 311.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. India Glycols's current Market Cap is ₹76,719 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (NSE:INDIAGLYCO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹798.49, compared to a current price of ₹1,146.50 — trading 43.6% above its estimated fair value. The current Market Cap is ₹76,719 Mil. India Glycols' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For India Glycols (NSE:INDIAGLYCO), the current Market Cap is ₹76,719 Mil as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is India Glycols (NSE:INDIAGLYCO) Overvalued in 2026?
Based on GuruFocus' analysis, India Glycols stock appears to be overvalued.
The current stock price of ₹1,146.50 is trading 43.6% above its estimated GF Value™ of ₹798.49.
GuruFocus considers India Glycols to be Significantly Overvalued.
Key valuation signals for NSE:INDIAGLYCO:
Market Cap: ₹76,719 Mil
GF Value™: ₹798.49 vs. price of ₹1,146.50 (43.6% above fair value)
No single metric tells the full story. See the NSE:INDIAGLYCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
73GF Score
Get the complete analysis for NSE:INDIAGLYCO
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDIAGLYCO has been successfully added to your 
